Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy

References

• TranosPGWickremasingheSSStangosNTTopouzisTTsinopoulosIPavesioCEMacular edemaSurv Ophthalmol20044947049015325193
   PubMed Web of Science ®Google Scholar
• GallemoreRPNSAIDs in treatment of retinal disordersRev Ophth2006138188
   Google Scholar
• PoweNRScheinODGieserSCSynthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research TeamArch Ophthalmol19941122392528037792
   PubMed Web of Science ®Google Scholar
• UrsellPGSpaltonDJWhitcupSMNussenblattRBCystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuityJ Cataract Refract Surg1999251492149710569164
   PubMed Web of Science ®Google Scholar
• HayashiKIgarashiCHirataAHayashiHChanges in diabetic macular oedema after phacoemulsification surgeryEye (Lond)20092338939617962820
   PubMed Web of Science ®Google Scholar
• DegenringRFVeySKamppeterBBuddeWMJonasJBSauderGEffect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjectsGraefes Arch Clin Exp Ophthalmol2007245182316865374
   PubMed Web of Science ®Google Scholar
• RossettiLAutelitanoACystoid macular edema following cataract surgeryCurr Opin Ophthalmol200011657210724830
   PubMedGoogle Scholar
• JohnsonMWEtiology and treatment of macular edemaAm J Ophthalmol2009147112118789796
   PubMed Web of Science ®Google Scholar
• DowlerJGSehmiKSHykinPGHamiltonAMThe natural history of macular edema after cataract surgery in diabetesOphthalmology199910666366810201584
   PubMed Web of Science ®Google Scholar
• PollackALeibaHBukelmanAOliverMCystoid macular oedema following cataract extraction in patients with diabetesBr J Ophthalmol1992762212241390489
   PubMed Web of Science ®Google Scholar
• PollackALeibaHBukelmanAAbrahamiSOliverMThe course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulationBr J Ophthalmol1992762282311390491
   PubMed Web of Science ®Google Scholar
• KreplerKBiowskiRSchreySJandrasitsKWedrichACataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedemaGraefes Arch Clin Exp Ophthalmol200224073573812271370
   PubMed Web of Science ®Google Scholar
• MiyakeKIbarakiNProstaglandins and cystoid macular edemaSurv Ophthalmol200247Suppl 1S203S21812204717
   PubMed Web of Science ®Google Scholar
• FlachAJThe incidence, pathogenesis and treatment of cystoid macular edema following cataract surgeryTrans Am Ophthalmol Soc19989655763410360304
   PubMedGoogle Scholar
• O’BrienTPEmerging guidelines for use of NSAID therapy to optimize cataract surgery patient careCurr Med Res Opin2005211131113716004683
   PubMed Web of Science ®Google Scholar
• RossettiLChaudhuriJDickersinKMedical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysisOphthalmology19981053974059499767
   PubMed Web of Science ®Google Scholar
• HendersonBAKimJYAmentCSFerrufino-PonceZKGrabowskaACremersSLClinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatmentJ Cataract Refract Surg2007331550155817720069
   PubMed Web of Science ®Google Scholar
• GaynesBIOnyekwulujeATopical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspensionClin Ophthalmol2008235536819668727
   PubMedGoogle Scholar
• KeTLGraffGSpellmanJMYanniJMNepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriersInflammation20002437138410850858
   PubMed Web of Science ®Google Scholar
• LaneSSNepafenac: a unique nonsteroidal prodrugInt Ophthalmol Clin200646132017060788
   PubMedGoogle Scholar
• KapinMAYanniJMBradyMTInflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenacInflammation20032728129114635785
   PubMed Web of Science ®Google Scholar
• WilkinsonCPFerrisFL3rdKleinREProposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology20031101677168213129861
   PubMed Web of Science ®Google Scholar
• KimSJBelairMLBresslerNMA method of reporting macular edema after cataract surgery using optical coherence tomographyRetina20082887087618536605
   PubMed Web of Science ®Google Scholar
• KimSJEquiRBresslerNMAnalysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomographyOphthalmology200711488188917275910
   PubMed Web of Science ®Google Scholar
• HeeMRPuliafitoCADukerJSTopography of diabetic macular edema with optical coherence tomographyOphthalmology19981053603709479300
   PubMed Web of Science ®Google Scholar
• HeeMRPuliafitoCAWongCQuantitative assessment of macular edema with optical coherence tomographyArch Ophthalmol1995113101910297639652
   PubMedGoogle Scholar
• GoebelWKretzchmar-GrossTRetinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT)Retina20022275976712476103
   PubMed Web of Science ®Google Scholar
• GoebelWFrankeRRetinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photographyRetina200626495716395139
   PubMed Web of Science ®Google Scholar
• CampbellRJCouplandSGBuhrmannRRKertesPJOptimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thicknessArch Ophthalmol200712561962317502499
   PubMedGoogle Scholar
• BresslerNMEdwardsARAntoszykANRetinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathyAm J Ophthalmol200814589490118294608
   PubMed Web of Science ®Google Scholar
• WolfEJBraunsteinAShihCBraunsteinREIncidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenacJ Cataract Refract Surg2007331546154917720068
   PubMed Web of Science ®Google Scholar
• HariprasadSMAkdumanLCleverJAOberMRecchiaFMMielerWFTreatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%Clin Ophthalmol2009314715419668559
   PubMedGoogle Scholar
• HariprasadSMCallananDGaineySHeYGWarrenKCystoid and diabetic macular edema treated with nepafenac 0.1%J Ocul Pharmacol Ther20072358559018001248
   PubMed Web of Science ®Google Scholar
• CallananDWilliamsPTopical nepafenac in the treatment of diabetic macular edemaClin Ophthalmol2008268969219668417
   PubMedGoogle Scholar
• KrzystolikMGStrauberSFAielloLPDiabetic Retinopathy Clinical Research NetworkReproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edemaOphthalmology20071141520152517353052
   PubMed Web of Science ®Google Scholar
• Nevanac^® (full prescribing information)Fort Worth, TXAlcon Laboratories Inc2008
   Google Scholar
• HeierJSToppingTMBaumannWDirksMSChernSKetorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edemaOphthalmology20001072034203811054327
   PubMed Web of Science ®Google Scholar